In DepthIMMUNOTHERAPY

Personalized tumor vaccines keep cancer in check

See allHide authors and affiliations

Science  14 Apr 2017:
Vol. 356, Issue 6334, pp. 122
DOI: 10.1126/science.356.6334.122

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed.  Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

  • Stimulation of endogenous stem cells in controlled eosinophilic syndrome against cancer
    • Andrey Ostanin, President, researcher, professor, Scientific Production System “Fertility & Ecology”

    Stimulation of endogenous stem cells in controlled eosinophilic syndrome against cancer

    Andrey L. Ostanin 1,*
    (1) Scientific Production System “Fertility & Ecology”
    * Email: fertility.ecology@gmail.com

    1. Summary
    While analyzing the influence of immunocompetent cells to malignant neoplasms, we faced a natural deficiency of leukocyte granulocytes in majority of cancer patients. Scientific articles [1-4] prove the efficiency of eosinophil peroxidase toxic proteins in the fight against cancer. It is a natural anti-cancer defense mechanism, open to everyone. However, this mechanism often fails for several reasons. Immunity is trying to fix the problem, but production of immunocompetent cells lags behind the proliferation of cancer cells. There is an urgent need to stimulate endogenous stem cells, or rather to stimulate hematopoietic stem cells to produce more eosinophils, which proved their higher anti-cancer efficiency than T cells. It is also necessary to stimulate hematopoietic stem cells, because it is important to inhibit telomerase [5-11], i.e. to turn immortal cancer cells back into normal ones living by the laws of apoptosis. To effectively meet these challenges it was necessary to raise regenerative activity of stem cells, or hematopoietic stem cells, several-fold.
    2. Description of the mechanisms or pathways involved in the stimulation of endogenous stem cells
    To avoid...

    Show More
    Competing Interests: None declared.